NDAOPHTHALMICSOLUTION/DROPS
Approved
Apr 2024
Lifecycle
Growth
Competitive Pressure
8/100
Clinical Trials
19
Data completeness
5/8 — Partial
LUMIFY PRESERVATIVE FREE (brimonidine tartrate) by Bausch + Lomb is alpha-2 adrenergic receptor agonist with a peak ocular hypotensive effect occurring at two hours post-dosing. Approved for ocular hypertension, open-angle glaucoma, glaucoma. First approved in 2024.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LUMIFY PRESERVATIVE FREE is a brimonidine tartrate ophthalmic solution approved in April 2024 for treating ocular hypertension and open-angle glaucoma. It is an alpha-2 adrenergic receptor agonist that reduces intraocular pressure through dual mechanisms: decreased aqueous humor production and increased uveoscleral outflow. The preservative-free formulation addresses tolerability and compliance concerns in the glaucoma market.
Growth4.2 years to LOE
Early-stage growth product with 4.2 years of patent protection; brand team will focus on market penetration and differentiation from AbbVie's ALPHAGAN P in a moderately competitive space.
Mechanism of Action
alpha-2 adrenergic receptor agonist with a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that brimonidine tartrate has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.
Indications (3)
Worked on LUMIFY PRESERVATIVE FREE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.